We are monitoring the impact of COVID-19 & Recession alarm on Antifungal Drugs Market Get in touch with us for detailed analysis Know More
Share on

Global Antifungal Drugs Market Size, Share, Trends, Growth & COVID-19 Impact Analysis Report – Segmented By Drug Type, Therapeutic Indications, Application & Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 212
Pages: 145

Global Antifungal Drugs Market Size (2022 to 2027)

As per our report, the global antifungal drugs market size was worth USD 13.54 billion in 2022. It is further estimated to be growing at a CAGR of 3.68% and a value of USD 16.22 billion by 2027. The market is expected to grow enormously in the next few years with the growing population across the world.

Antifungal Drugs Market

Antifungal drugs are mainly used to treat various infections like athlete’s foot, ringworm, candidiasis, etc. These drugs can be easily obtained through a doctor’s prescription, whereas some are available as over-the-counter drugs. The drugs are manufactured with different formulas for various infections accordingly. Fungal infections occur because organisms feed by breaking down the living tissue, also known as dermatophytes. They can utilize keratin and cause infection over skin, hair, and nails. The only aim of these drugs is to prevent the fungal cell from growing by making the cell's contents break out. Unhygienic environments may lead to severe conditions in causing an infection on the skin.

Impact of COVID-19 on the global antifungal drugs market:

The introduction of COVID-19 has accelerated the growth rate of the global antifungal drugs market. Patients with critical COVID-19 were found to have small amounts of Interferon (IFNs) in the blood or lungs. As per the research published in the British Journal of Pharmacology, two medicines are available for preventing COVID-19: an antifungal drug and an antidepressant. Patients with COVID-19 are exposed to developing pulmonary aspergillosis and found that the antifungal itraconazole and antidepressant fluoxetine stopped producing the infectious disease COVID-19 virus amid the cell culture lab test. The drug is used in combination with the antiviral drug remdesiver, and the combination exhibited a collective effect and restricted the virus production. Influential and safeguarding drug combination treatment of Isotretinoin and antifungal drugs works as a potential aerosol therapy for COVID-19 patients. Thus, with the COVID-19 favor, the global antifungal drugs market is expected to register new growth heights during the forecast period.

MARKET DRIVERS:

Y-O-Y growth in the prevalence of fungal and nosocomial diseases drives the worldwide antifungal drugs market.

Antifungal drugs have grown in popularity in recent years as the prevalence of various fungal infections has increased worldwide, as has the incidence of hospital-acquired illnesses and public awareness about personal cleanliness. In addition, increasing disposable income, improved healthcare infrastructure, various antifungal medications, and a growing focus on employing nanotechnology to formulate innovative drugs are all driving global market expansion. Furthermore, changes in the environmental conditions and a rise in the spread of various infectious diseases from person to person, and the growing number of fungal infections such as aspergillosis and candidiasis further propel the growth of the global antifungal drugs market. In addition, the rise in the concern for health and growing support from the government and non-government organizations over antifungal diseases is predicted to add fuel to the market's growth rate during the forecast period.

Adopting the latest technologies in producing various drugs and offering effective treatment procedures for different infectious diseases worldwide sets up growth opportunities for the market. In addition, a rise in the demand to improve safety levels is lavishing the demand of this market. Furthermore, increasing investments in research and development institutes are ascribed to bolster the market's growth. Increasing awareness over the availability of products through digital advertisements and campaigns thrives the demand of the global antifungal drugs market majorly.

Furthermore, the antifungal medications market is predicted to grow due to an increase in governmental and private sector initiatives to raise awareness about a variety of fungal illnesses. Clinical trials for the development of antifungal drugs are being conducted by market players, which is projected to boost the global antifungal pharmaceuticals market's growth throughout the forecast period. The market's growth pace will be accelerated by increasing medication approvals and launches and focusing on releasing generic medications to treat fungal infections.

MARKET RESTRAINTS:

The availability of alternate substitutes is silently hindering the growth of the global antifungal drugs market.

The rise in side effects of long-term use of these drugs has been a challenging market growth factor. Also, fluctuations in the drug's production rate are slowly inhibiting the demand in the antifungal drugs market. Furthermore, the lack of skilled persons in manufacturing the drugs also impedes the market's growth rate. In addition, stringent rules and regulations by the government in approving new drugs also limit the demand of the market.

In addition, the high cost of antifungal drugs is expected to slow the market's growth rate. The market for antifungal pharmaceuticals is also predicted to be challenged by the growing number of resistant people to antifungal drugs and a lack of healthcare infrastructure in underdeveloped countries.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Drug Type, Therapeutic Indications, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This market research report on the global antifungal drugs market has been segmented and sub-segmented based on drug type, therapeutic indications, application, and region.

Antifungal Drugs Market - By Drug Type:

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

Based on the drug type, The azoles segment holds a significant proportion of the antifungal drugs market and is expected to rise significantly during the forecast period. Azoles are used to treat various ailments, such as yeast infection, tinea versicolor, and athlete's foot, and come in a variety of forms, including capsules, lotions, and sterile IV solutions. These medications have better absorption and distribution qualities and fewer adverse effects and drug interactions.

On the other hand, the echinocandins segment is predicted to grow at a healthy rate from 2022 to 2027.

Antifungal Drugs Market - By Therapeutic Indications:

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

Based on the therapeutic indication, the most prevalent systemic fungal infection, candidiasis, is anticipated to grow at the quickest rate during the forecast period in the global antifungal drugs market. Candida infection is a type of yeast infection caused by the genus Candida. The way it's been treated has changed over time. The judicious use of echinocandins and broad-spectrum azoles for the treatment of candidemia, mucosal candidiasis, and invasive candidiasis are among the changes. A primary driver for the segment is the rising number of patients who are more sensitive to fungal infections. Furthermore, rising patient and healthcare professional awareness is expected to propel the antifungal drugs market forward.

Antifungal Drugs Market - By Application:

  • Powders
  • Ointments
  • Drugs
  • Pastes

Based on the application, the ointment segment emerged as the market leader in the worldwide antifungal drugs market. Over the forecast period, the market is expected to rise due to the increasing usage of topical antifungals in treating skin-related fungal diseases.

Antifungal Drugs Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American antifungal drugs market is predicted to occupy most of the market share in the global market during the forecast period due to the rapid adoption of the latest technologies. The introduction of various types of drugs with high quality and low cost is prompting the market's growth rate in this region. Due to the priority review status for antifungal medications to treat antifungal infection, North America is likely to see considerable growth in the global antifungal drugs market during the forecast period. Due to improved healthcare infrastructure, an increase in echinocandin resistance, and an increase in the number of fungal infections in the region, North America also holds a significant share in the global antifungal drugs market. The United States is one of the world's most economically developed nations. Therefore, it currently controls a substantial portion of the market. In addition, infections caused by fungi have posed a problem for health officials in the United States. This ongoing fungal proliferation will allow nation pharmacists to produce compelling novel and anti-fungal novels, resulting in market growth.

During the forecast period, the European antifungal drugs market is expected to be the second-largest regional market in the global market. Increasing funds from private and public organizations to evaluate quality treatment procedures is surging the growth of the European antifungal drugs market.  

However, the Asia Pacific antifungal drugs market is forecasted to be the fastest-growing region globally between 2022 to 2027. It is estimated to register a tremendous growth rate in the foreseen years. An increasing number of infectious disease cases due to unhygienic environments in rural areas is a significant factor magnifying the growth of the market. The Middle East and Africa are anticipated to have substantial growth opportunities soon.

KEY MARKET PARTICIPANTS:

Noteworthy players leading the global antifungal drugs market in this report are Gilead Sciences, Inc., Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc.

RECENT MARKET DEVELOPMENTS:

  • In January 2020, the FDA approved its supplement New Drug Application (sNDA) for MYCAMINE to support the treatment of Candidemia.  
  • In December 2019, Astellas Pharma Inc. and Xyphos Biosciences, Inc. announced that Astellas had acquired Xiphos. Astellas will gain Xyphos novel and proprietary ACCEL technology platform and industry-leading immune-oncology talent with the acquisition. 
  • In October 2019, Astellas committed nearly $13Million to fund Boston – Area Start-Up Innovation in Cell and Gene Therapy. 
  • In October 2019, Pandion Therapeutics and Astellas Pharma Inc. announced a License and Collaboration Agreement directed toward the research, development, and commercialization of locally acting immune modulators for autoimmune diseases in the pancreas. 
  • In December 2019, Astellas Pharma Inc., a Tokyo-based company, ALPMY, announced that it had acquired privately-held development-stage biotechnology company Xyphos Biosciences, Inc. to boost its immune-oncology pipeline. 
  • n November 2019, Astellas Pharma Inc. announced that the China National Medical Products Administration (NMPA) approved a new drug application for XTANDI to treat adult men with metastatic castration-resistant prostate cancer that is asymptomatic or mildly symptomatic. 
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Drug Type
      1. Echinocandins
      2. Azoles
      3. Polyenes
      4. Allylamines
      5. Others
    2. By Therapeutic Indications
      1. Aspergillosis
      2. Dermatophytosis
      3. Candidiasis
      4. Others
    3. By Application
      1. Powders
      2. Ointments
      3. Drugs
      4. Pasters
  6. Geographical Analysis
    1. North America
      1. Introduction
      2. United States
      3. Canada
    2. Europe
      1. Introduction
      2. U.K
      3. Spain
      4. Germany
      5. Italy
      6. France
    3. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
      5. South Korea
      6. Australia
    4. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
      5. Rest of Latin America
    5. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Alternaria
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Pfizer
    3. Novartis
    4. Sanofi-Aventis
    5. Merck & Co.
    6. Asperqillus
    7. Kramer Laboratories
    8. Bayer Healthcare
    9. Enzon Pharmaceuticals
    10. Glaxosmithkline Gilead
    11. Abbott Laboratories
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3.  Agreements, collaborations and Joint Ventures
    4. New Product Launches
  10. Expert Opinions
    1. Market Outlook
    2. Investment Opportunities
  1. Antifungal Drugs Market, By Region, From 2022 - 2027 (USD Million)
  2. Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  3. Echinocandins Market, By Region, From 2022 - 2027 (USD Million)
  4. Azoles Market, By Region, From 2022 - 2027 (USD Million)
  5. Polyenes Market, By Region, From 2022 - 2027 (USD Million)
  6. Allylamines Market, By Region, From 2022 - 2027 (USD Million)
  7. Other Drugs Market, By Region, From 2022 - 2027 (USD Million)
  8. Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  9. Aspergillosis Market, By Region, From 2022 - 2027 (USD Million)
  10. Dermatophytosis Market, By Region, From 2022 - 2027 (USD Million)
  11. Candidiasis Market, By Region, From 2022 - 2027 (USD Million)
  12. Other Therapeutic Indications Market, By Region, From 2022 - 2027 (USD Million)
  13. Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  14. Powders Market, By Region, From 2022 - 2027 (USD Million)
  15. Ointments Market, By Region, From 2022 - 2027 (USD Million)
  16. Drugs Market, By Region, From 2022 - 2027 (USD Million)
  17. Pastes Market, By Region, From 2022 - 2027 (USD Million)
  18. North America Antifungal Drugs Market, By Region, From 2022 - 2027 (USD Million)
  19. North America Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  20. North America Echinocandins Market, By Region, From 2022 - 2027 (USD Million)
  21. North America Azoles Market, By Region, From 2022 - 2027 (USD Million)
  22. North America Polyenes Market, By Region, From 2022 - 2027 (USD Million)
  23. North America Allylamines Market, By Region, From 2022 - 2027 (USD Million)
  24. North America Other Drugs Market, By Region, From 2022 - 2027 (USD Million)
  25. North America Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  26. North America Aspergillosis Market, By Region, From 2022 - 2027 (USD Million)
  27. North America Dermatophytosis Market, By Region, From 2022 - 2027 (USD Million)
  28. North America Candidiasis Market, By Region, From 2022 - 2027 (USD Million)
  29. North America Other Therapeutic Indications Market, By Region, From 2022 - 2027 (USD Million)
  30. North America Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  31. North America Powders Market, By Region, From 2022 - 2027 (USD Million)
  32. North America Ointments Market, By Region, From 2022 - 2027 (USD Million)
  33. North America Drugs Market, By Region, From 2022 - 2027 (USD Million)
  34. North America Pastes Market, By Region, From 2022 - 2027 (USD Million)
  35. United States Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  36. United States Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  37. United States Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  38. Canada Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  39. Canada Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  40. Canada Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  41. Europe Antifungal Drugs Market, By Region, From 2022 - 2027 (USD Million)
  42. Europe Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  43. Europe Echinocandins Market, By Region, From 2022 - 2027 (USD Million)
  44. Europe Azoles Market, By Region, From 2022 - 2027 (USD Million)
  45. Europe Polyenes Market, By Region, From 2022 - 2027 (USD Million)
  46. Europe Allylamines Market, By Region, From 2022 - 2027 (USD Million)
  47. Europe Other Drugs Market, By Region, From 2022 - 2027 (USD Million)
  48. Europe Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  49. Europe Aspergillosis Market, By Region, From 2022 - 2027 (USD Million)
  50. Europe Dermatophytosis Market, By Region, From 2022 - 2027 (USD Million)
  51. Europe Candidiasis Market, By Region, From 2022 - 2027 (USD Million)
  52. Europe Other Therapeutic Indications Market, By Region, From 2022 - 2027 (USD Million)
  53. Europe Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  54. Europe Powders Market, By Region, From 2022 - 2027 (USD Million)
  55. Europe Ointments Market, By Region, From 2022 - 2027 (USD Million)
  56. Europe Drugs Market, By Region, From 2022 - 2027 (USD Million)
  57. Europe Pastes Market, By Region, From 2022 - 2027 (USD Million)
  58. U.K Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  59. U.K Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  60. U.K Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  61. Spain Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  62. Spain Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  63. Spain Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  64. Germany Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  65. Germany Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  66. Germany Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  67. Italy Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  68. Italy Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  69. Italy Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  70. France Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  71. France Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  72. France Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  73. Asia-Pacific Antifungal Drugs Market, By Region, From 2022 - 2027 (USD Million)
  74. Asia-Pacific Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  75. Asia-Pacific Echinocandins Market, By Region, From 2022 - 2027 (USD Million)
  76. Asia-Pacific Azoles Market, By Region, From 2022 - 2027 (USD Million)
  77. Asia-Pacific Polyenes Market, By Region, From 2022 - 2027 (USD Million)
  78. Asia-Pacific Allylamines Market, By Region, From 2022 - 2027 (USD Million)
  79. Asia-Pacific Other Drugs Market, By Region, From 2022 - 2027 (USD Million)
  80. Asia-Pacific Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  81. Asia-Pacific Aspergillosis Market, By Region, From 2022 - 2027 (USD Million)
  82. Asia-Pacific Dermatophytosis Market, By Region, From 2022 - 2027 (USD Million)
  83. Asia-Pacific Candidiasis Market, By Region, From 2022 - 2027 (USD Million)
  84. Asia-Pacific Other Therapeutic Indications Market, By Region, From 2022 - 2027 (USD Million)
  85. Asia-Pacific Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  86. Asia-Pacific Powders Market, By Region, From 2022 - 2027 (USD Million)
  87. Asia-Pacific Ointments Market, By Region, From 2022 - 2027 (USD Million)
  88. Asia-Pacific Drugs Market, By Region, From 2022 - 2027 (USD Million)
  89. Asia-Pacific Pastes Market, By Region, From 2022 - 2027 (USD Million)
  90. China Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  91. China Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  92. China Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  93. India Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  94. India Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  95. India Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  96. Japan Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  97. Japan Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  98. Japan Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  99. South Korea Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  100. South Korea Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  101. South Korea Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  102. Australia Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  103. Australia Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  104. Australia Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  105. Latin America Antifungal Drugs Market, By Region, From 2022 - 2027 (USD Million)
  106. Latin America Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  107. Latin America Echinocandins Market, By Region, From 2022 - 2027 (USD Million)
  108. Latin America Azoles Market, By Region, From 2022 - 2027 (USD Million)
  109. Latin America Polyenes Market, By Region, From 2022 - 2027 (USD Million)
  110. Latin America Allylamines Market, By Region, From 2022 - 2027 (USD Million)
  111. Latin America Other Drugs Market, By Region, From 2022 - 2027 (USD Million)
  112. Latin America Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  113. Latin America Aspergillosis Market, By Region, From 2022 - 2027 (USD Million)
  114. Latin America Dermatophytosis Market, By Region, From 2022 - 2027 (USD Million)
  115. Latin America Candidiasis Market, By Region, From 2022 - 2027 (USD Million)
  116. Latin America Other Therapeutic Indications Market, By Region, From 2022 - 2027 (USD Million)
  117. Latin America Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  118. Latin America Powders Market, By Region, From 2022 - 2027 (USD Million)
  119. Latin America Ointments Market, By Region, From 2022 - 2027 (USD Million)
  120. Latin America Drugs Market, By Region, From 2022 - 2027 (USD Million)
  121. Latin America Pastes Market, By Region, From 2022 - 2027 (USD Million)
  122. Brazil Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  123. Brazil Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  124. Brazil Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  125. Argentina Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  126. Argentina Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  127. Argentina Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  128. Mexico Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  129. Mexico Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  130. Mexico Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  131. Rest of Latin America Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  132. Rest of Latin America Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  133. Rest of Latin America Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  134. Middle East & Africa Antifungal Drugs Market, By Region, From 2022 - 2027 (USD Million)
  135. Middle East & Africa Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  136. Middle East & Africa Echinocandins Market, By Region, From 2022 - 2027 (USD Million)
  137. Middle East & Africa Azoles Market, By Region, From 2022 - 2027 (USD Million)
  138. Middle East & Africa Polyenes Market, By Region, From 2022 - 2027 (USD Million)
  139. Middle East & Africa Allylamines Market, By Region, From 2022 - 2027 (USD Million)
  140. Middle East & Africa Other Drugs Market, By Region, From 2022 - 2027 (USD Million)
  141. Middle East & Africa Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  142. Middle East & Africa Aspergillosis Market, By Region, From 2022 - 2027 (USD Million)
  143. Middle East & Africa Dermatophytosis Market, By Region, From 2022 - 2027 (USD Million)
  144. Middle East & Africa Candidiasis Market, By Region, From 2022 - 2027 (USD Million)
  145. Middle East & Africa Other Therapeutic Indications Market, By Region, From 2022 - 2027 (USD Million)
  146. Middle East & Africa Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  147. Middle East & Africa Powders Market, By Region, From 2022 - 2027 (USD Million)
  148. Middle East & Africa Ointments Market, By Region, From 2022 - 2027 (USD Million)
  149. Middle East & Africa Drugs Market, By Region, From 2022 - 2027 (USD Million)
  150. Middle East & Africa Pastes Market, By Region, From 2022 - 2027 (USD Million)
  151. Middle East Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  152. Middle East Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  153. Middle East Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  154. Africa Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  155. Africa Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  156. Africa Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

FAQ's

How much is the global antifungal drugs market going to be worth by 2027?

As per our research report, the global antifungal drugs market size is estimated to be worth USD 16.22 billion by 2027.

Does this report include the impact of COVID-19 on the antifungal drugs market?

Yes, we have studied and included the COVID-19 impact on the global antifungal drugs market in this report.

Which segment by drug type led the antifungal drugs market in 2021?

Based on drug type, the azoles segment dominated the antifungal drugs market in 2021.

Which are the companies playing a key role in the global antifungal drugs market?

Gilead Sciences, Inc., Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc. are playing a major role in the global antifungal drugs market.

Related Reports

PURCHASE OPTIONS

excel
$

4255


pdf excel
$

5060


pdf excel powerbi
$

7360


excel
$

2500

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample